Arcticzymes Technologies (Norway) Today
| AZT Stock | NOK 13.18 0.06 0.45% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Arcticzymes Technologies is selling for 13.18 as of the 21st of November 2024. This is a 0.45% down since the beginning of the trading day. The stock's lowest day price was 12.9. Arcticzymes Technologies has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Arcticzymes Technologies ASA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of December 2022 and ending today, the 21st of November 2024. Click here to learn more.
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and markets recombinant enzymes derived from cold-water marine species and organisms from other relevant environments for use in molecular research, in vitro diagnostics , and therapeutics in Norway, Europe, Asia, Australia, Africa, and the Americas. The company has 50.57 M outstanding shares. More on Arcticzymes Technologies ASA
Moving together with Arcticzymes Stock
Moving against Arcticzymes Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Arcticzymes Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Arcticzymes Technologies' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Arcticzymes Technologies or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Biotechnology, Healthcare, Computing (View all Sectors) |
Arcticzymes Technologies ASA (AZT) is traded on Oslo Stock Exchange in Norway and employs 60 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.13 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Arcticzymes Technologies's market, we take the total number of its shares issued and multiply it by Arcticzymes Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Arcticzymes Technologies operates under Healthcare sector and is part of Biotechnology industry. The entity has 50.57 M outstanding shares.
Arcticzymes Technologies ASA has accumulated about 200.42 M in cash with 74.97 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.52.
Check Arcticzymes Technologies Probability Of Bankruptcy
Ownership AllocationArcticzymes Technologies holds a total of 50.57 Million outstanding shares. Arcticzymes Technologies ASA retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Arcticzymes Ownership Details
Arcticzymes Technologies Risk Profiles
Although Arcticzymes Technologies' alpha and beta are two of the key measurements used to evaluate Arcticzymes Technologies' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.08 | |||
| Standard Deviation | 3.4 | |||
| Variance | 11.56 | |||
| Risk Adjusted Performance | (0.13) |
Arcticzymes Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Arcticzymes Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Arcticzymes Technologies Corporate Management
Elected by the shareholders, the Arcticzymes Technologies' board of directors comprises two types of representatives: Arcticzymes Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Arcticzymes. The board's role is to monitor Arcticzymes Technologies' management team and ensure that shareholders' interests are well served. Arcticzymes Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Arcticzymes Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marit Lorentzen | VP Operations | Profile | |
| Borge Sorvoll | Chief Officer | Profile | |
| Darren Ellis | Chief Officer | Profile | |
| Alexander Bjorna | Director Devel | Profile | |
| Jethro Holter | Chief Officer | Profile | |
| Dirk Hahneiser | VP Marketing | Profile |
Other Information on Investing in Arcticzymes Stock
Arcticzymes Technologies financial ratios help investors to determine whether Arcticzymes Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arcticzymes with respect to the benefits of owning Arcticzymes Technologies security.